Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Fax written comments on the collection of information by September 30, 2013.
To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202-395-7285, or emailed to firstname.lastname@example.org. All comments should be identified with the OMB control number 0910-0454 and title “Guidance for Industry # 108 on How to Submit Information in Electronic Format to CVM Using the FDA Electronic Submission Gateway.” Also include the FDA docket number found in brackets in the heading of this document.
Start Further Info
FOR FURTHER INFORMATION CONTACT:
FDA PRA Staff, Office of Operations, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, PRAStaff@fda.hhs.gov.
End Further Info
Start Supplemental Information
In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.
Guidance for Industry # 108 on How To Submit Information in Electronic Format to CVM Using the FDA Electronic Submission Gateway—21 CFR 11.2 (OMB Control Number 0910-0454)—Extension
The Center for Veterinary Medicine (CVM) accepts certain types of submissions electronically with no requirement for a paper copy. These types of documents are listed in public docket 97S-0251 as required by § 11.2 (21 CFR 11.2). CVM's ability to receive and process information submitted electronically is limited by its current information technology capabilities and the requirements of the Electronic Records; Electronic Signatures final regulation. CVM's guidance entitled “Guidance for Industry # 108: How to Submit Information in Electronic Format to CVM Using the FDA Electronic Submission Gateway” outlines general standards to be used for the submission of any information by email. The likely respondents are sponsors for new animal drug applications.
In the Federal Register of May 16, 2013 (78 FR 28851), FDA published a 60-day notice requesting public comment on the proposed collection of information. No comments were received.
FDA estimates the burden of this collection of information as follows:
Table 1—Estimated Annual Reporting Burden 1
|21 CFR Part and Form FDA||Number of respondents||Number of responses per
respondent||Total annual responses||Average burden per response||Total hours|
|§ 11.2; Form FDA 3538||65||2.4||156||.08 (5 minutes)||13 (Rounded from 12.5)|
|1 There are no capital costs or operating and maintenance costs associated with this collection of information.|
Start Printed Page 53773
End Supplemental Information
Dated: August 27, 2013.
Assistant Commissioner for Policy.
[FR Doc. 2013-21236 Filed 8-29-13; 8:45 am]
BILLING CODE 4160-01-P